Received Nov 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EK4176 | IM / LA |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | EK5730 | IM / LA |
Developed difficulty with amenorrhea, painful periods after the vaccine; this was noticed by the next menstrual cycle. Developed axillary lymphadenopathy and a right breast lump approximately 6 weeks after the second vaccine.
Celiac Disease
gluten
Ultrasound of right breast 4/9/2021
Influenza Quad vaccine, GlaxoSmithKline Lot#2GR7X Dose 0.5 mL also developed worsening axillary lymphadenopathy, menstrual cycle